Merck Manual

Please confirm that you are a health care professional

honeypot link

Wiskott-Aldrich Syndrome


James Fernandez

, MD, PhD, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University

Last full review/revision Apr 2021| Content last modified Sep 2022
Click here for Patient Education

Wiskott-Aldrich syndrome results from a combined B- and T-cell defect and is characterized by recurrent infection, eczema, and thrombocytopenia.

Inheritance is X-linked recessive. Wiskott-Aldrich syndrome is caused by mutations in the gene that encodes the Wiskott-Aldrich syndrome protein (WASP), a cytoplasmic protein necessary for normal B- and T-cell signaling.

Symptoms and Signs of Wiskott-Aldrich Syndrome

The first manifestations are often hemorrhagic (usually bloody diarrhea), followed by recurrent respiratory infections, eczema, and thrombocytopenia.

Diagnosis of Wiskott-Aldrich Syndrome

  • Immunoglobulin levels

  • Platelet count and volume assessment

  • White blood cell function tests (eg, neutrophil chemotaxis, T-cell function)

Diagnosis of Wiskott-Aldrich syndrome is based on the following:

  • Decreased T-cell count and function

  • Elevated IgE and IgA levels

  • Low IgM levels

  • Low or normal IgG levels

  • Decreased natural killer cell cytotoxicity

  • Impaired neutrophil chemotaxis

Antibodies to polysaccharide antigens (eg, blood group antigens A and B) may be selectively deficient. Platelets are small and defective, and splenic destruction of platelets is increased, causing thrombocytopenia Overview of Platelet Disorders Platelets are circulating cell fragments that function in the clotting system. Thrombopoietin helps control the number of circulating platelets by stimulating the bone marrow to produce megakaryocytes... read more Overview of Platelet Disorders . Mutation analysis may be used to confirm the diagnosis.

Genetic testing is recommended for 1st-degree relatives.

Because risk of lymphoma and leukemia is increased, a complete blood count with differential is usually done every 6 months. Acute changes in symptoms related to B-cell dysfunction require more in-depth evaluations.

Treatment of Wiskott-Aldrich Syndrome

  • Supportive care using prophylactic immune globulin, antibiotics, and acyclovir

  • For symptomatic thrombocytopenia, platelet transfusion and rarely splenectomy

  • Hematopoietic stem cell transplantation

Treatment of Wiskott-Aldrich syndrome is prophylactic antibiotics and immune globulin Replacement of missing immune components Immunodeficiency typically manifests as recurrent infections. However, recurrent infections are more likely to have causes other than immunodeficiency (eg, inadequate treatment, resistant organisms... read more to prevent recurrent bacterial infections, acyclovir to prevent severe herpes simplex virus infections, and platelet transfusions to treat hemorrhage. If thrombocytopenia is severe, splenectomy can be done, but it is usually avoided because it increases risk of septicemia.

Without transplantation, most patients die by age 15; however, some patients survive into adulthood.

Drugs Mentioned In This Article

Drug Name Select Trade
Gammagard S/D
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
quiz link

Test your knowledge

Take a Quiz!